AG
AMAG

Aperio Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Aperio Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,178
Closed -$187K – 2358
2019
Q3 		$187K Buy
16,178
+8,417
+108% +$88.6K ﹤0.01% 2179
2019
Q2 		$78K Buy
+7,761
New +$83.7K ﹤0.01% 2455
2018
Q1 		– Sell
-11,032
Closed -$146K – 2277
2017
Q4 		$146K Buy
11,032
+302
+3% +$4.55K ﹤0.01% 2177
2017
Q3 		$198K Buy
+10,730
New +$200K ﹤0.01% 2124
2017
Q2 		– Sell
-10,296
Closed -$232K – 2230
2017
Q1 		$232K Sell
10,296
-3,010
-23% -$72.1K ﹤0.01% 1964
2016
Q4 		$463K Buy
13,306
+3,984
+43% +$119K ﹤0.01% 1547
2016
Q3 		$228K Buy
+9,322
New +$233K ﹤0.01% 1876
2015
Q3 		– Sell
-3,218
Closed -$222K – 2029
2015
Q2 		$222K Buy
+3,218
New +$202K ﹤0.01% 1803

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Aperio Group's AMAG Position: Q4 2019 in Review

Aperio Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 16,178 shares — an estimated $187K sold.

Aperio Group first reported a position in AMAG in Q2 2015 and held it in 8 quarters. The position peaked at $463K in Q4 2016. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Aperio Group reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Aperio Group sold 16,178 AMAG Pharmaceuticals shares in Q4 2019, an estimated $187K.
  • Aperio Group first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 8 quarters.
  • Aperio Group's AMAG Pharmaceuticals position peaked at $463K in Q4 2016.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.